Connect with us

EU

#ArtificialIntelligence can improve quality of life but potential risks remain says #EESC

Published

on

A delegation of members of the European Economic and Social Committee (EESC) visited three Finnish technological hubs to assess the potential benefits and dangers of artificial intelligence for our society. They stressed that all future developments must encompass three pillars: product safety, consumer trust, and solidarity in health and social care.

Artificial intelligence applications can increase people's wellbeing, but the potential risks need to be taken seriously. The products that are emerging as a result of new technologies and the digital revolution are in general extremely helpful and can have a wide range of uses in all areas of our lives, from dispensing medicines to curing loneliness. However, they need to be handled with care, as they are not always as straightforward as they may seem.

In order to evaluate the opportunities and challenges in a practical way, a delegation of EESC members visited three Finnish organisations involved in developing digital technologies. They assessed the potential benefits and dangers for our society and agreed that any future developments in artificial intelligence should take place with real people as the reference point, in particular in terms of the safety of the products, consumer trust and solidarity in the health and social care sectors. Technology is a tool that can make our lives easier and help society solve its problems, but it must always be human-driven.

People at the core of artificial intelligence

"Safety comes first," said EESC member Franca Salis Madinier. "All artificial intelligence products can bring about major advantages, but the other side of the coin is that they can also be dangerous. These products are like medicines, it depends on how you use them. For this reason, they absolutely need to be tested and certified before they can be sold," she added. A European certification system for establishing standards is therefore extremely important, because in this way the manufacturers can declare that their products have been checked and there is no risk of harm to people. In addition to safety, other requirements include robustness, resilience and absence of prejudice, discrimination or bias.

Another crucial issue is trust. European citizens need to be able to know which businesses they can rely on. In this respect, EESC member Ulrich Samm recommended referring to trustworthy companies and professionals rather than "trusted algorithms". "A European label for trustworthy artificial intelligence companies is needed, one that is based on European values," he stressed. "Such a process would create a competitive advantage in the future, because it would make consumer confidence possible: people would be able to recognize companies and products that can be trusted," he stated.

The role of digital technologies is also key in the area of health and social care, where new forms of organisation and governance are being created. "The new digital tools should help implement and reinforce, rather than weaken, citizens' fundamental rights. People must always be at the heart of social care. Technology is supposed to support us and make our lives easier, not the other way around," pointed out EESC member Diego Dutto. "We must take advantage of the digital transformation to develop the potential of individuals, as well as that of local communities and social economies. The values of solidarity and universality must remain the basis of our healthcare systems and this should be ensured by means of appropriate public investment," he concluded.

EESC members' visit to technological hubs in Helsinki

The site visits of the members of the Committee took place near Helsinki on 22 November 2019, in conjunction with the EESC conference on artificial intelligence, robotics and digital services for the wellbeing of citizens, held in Helsinki the previous day. The first meeting was organised by the Technical Research Centre of Finland (VTT), where EESC members could discuss the latest developments in the field of robotics and explore the potential reach of quantum technology projects.

The second visit took place at the University of Applied Sciences (DIAK): the focus was on education, social competencies and technology to prevent isolation and help integration and equality. The final session took place at Airo Island and dealt with innovation and opportunities for business, showcasing specific case studies of products produced by start-up companies, such as the loop shower and the medicine dispenser robot.

A sleeping robot is just another example of the benefits that artificial intelligence can bring to human beings and our society as a whole. It is useful to counter insomnia, a widespread condition in industrialised countries, where it is estimated that about a third of the population experiences a sleeping disorder at least once in their lifetime. The causes of this can be multiple, such as stress or anxiety in the evening, but they all result in people having difficulty properly resting at night.

The sleeping robot may help us fall asleep. By holding it and following its advice and technique, our body will find it easier to relax. The right soft light, relaxing music and breathing exercises will do the rest, helping synchronize our heart rhythm with that of the machine. All in all, artificial intelligence may not be a one-size-fits-all solution, but it can certainly bring considerable benefits.

coronavirus

EAPM and ESMO bring innovations to health policymakers

Published

on

For the eighth year in succession, the European Alliance for Personalised Medicine (EAPM) has held a high-level conference series alongside the annual ESMO Congress, writes EAPM Executive Director Denis Horgan.

The EAPM conference was opened with the announcement that the following article was published and contributed to by more than 40 experts across the EU on how to bring Greater Accuracy to Europe’s Healthcare Systems: The Unexploited Potential of Biomarker Testing in Oncology.  Please click here to have access.

Sessions include: Session I: Tumor Agnostic, Session II: Biomarkers and Molecular Diagnostics, and Session III: Utilising Real-World Evidence in a health-care setting.  The conference runs from 08.00 – 16.00. Here is the link to the agenda. The conference aims to bring  key recommendations to the EU level, so as to shape the EU Beating Cancer Plan, EU health Data Space, the updating EU Pharmaceutical Strategy as well as the EU Health Union. 

The conference is held following the first State of the Union address by European Commission President Ursula von der Leyen on Wednesday (16 September) – in her first annual address, von der Leyen said the coronavirus pandemic had underlined the need for closer cooperation, stressing that people were “still suffering”.

For me, it is crystal clear – we need to build a stronger European Health Union,” she said. “And we need to strengthen our crisis preparedness and management of cross-border health threats.” Von der Leyen said her commission would try to reinforce the European Medicines Agency and European Centre for Disease Prevention and Control.

And she also raised the importance of the European Beating Cancer Plan as well as European Health Data Space. “This will show Europeans that our Union is there to protect all,” she said.

Fabrice Barlesi, medical director of Gustave Roussy, said: “RCTs are no longer the way to go. A way ahead could be EU support for trialing a new drug and delivering data to a centralised registry, which could give good consolidated data from across Europe.”

Divided into three sessions, the EAPM conference at the ESMO Congress, as mentioned,  dealt with such diverse issues as tumour agnostics, biomarkers and molecular diagnostics and real-world evidence in a health-care setting. Concerning cancer, specifically tumours, the congress stated that  tissue-agnostic cancer drugs are antineoplastic medicines that treat cancers based on the mutations that they display, instead of the tissue type in which they appear.

These drugs include, for example, Entrectinib, Pembrolizumab and Larotrectinib. Former Spanish health minister and MEP Dolors Moseratt highlighted her support for the work of EAPM and looks forward to getting the recommendations of the outcomes from the conference.  “The European added value of health is obvious. It would avoid duplication and enable a better allocation of resources. And it will minimize the risk of fragmented access to therapy across member states.”

And the EAPM conference is at pains to seek the best ways forward for the implementation of Real-World Evidence (RWE) into health care in Europe – looking to find consensus with key decision makers, including at member state level, not least with representatives in the European Parliament, on how to proceed in this area. RWE for health care is a simple concept – harnessing various health data in real time to help make faster and better medical decisions.

Real-World Evidence is an umbrella term for different types of health-care data that are not collected in conventional randomised controlled trials, including patient data, data from clinicians, hospital data, data from payers and social data.

Rosa Giuliani, consultant in medical oncology at the Clatterbridge Cancer Center, said: “Key elements to advance the use of TACs is to conduct dialogue that transcends silos, and to explore re-engineering of the development pathway.” And, as far as biomarkers and molecular diagnostics are concerned, a lot has been said about testing, and often the lack of it, in terms of the COVID-19 outbreak, with different countries adopting different strategies and, also, having different resources when it comes to acquiring necessary kits.

The key focus in the ESMO session was on better and more equitable access to biomarkers and molecular diagnostics across Europe.  This is a must, but, as the attendees acknowledged, we’re a long way short of it. Access to personalised medicine and new diagnostic technologies can help resolve many inefficiencies, such as trial-and-error dosing, the potential for increased hospitalisation time due to adverse drug reactions and the problem of late diagnoses. It may also enhance the effectiveness of therapies through better tailored treatment administration.

In conclusion for the morning session, Giuseppe Curigliano, associate professor of Medical Oncology at the University of Milano, and head of the division of Early Drug Development, at the European Institute of Oncology said: “A real challenge to overcome is the different endpoints between investigators and payers. Policy frameworks and co-operation is essential.” The session in the afternoon will focus on utilizing real-world evidence in a health-care setting.

A report will be available next week. 

Continue Reading

Brexit

EU's Barnier still hopes trade deal with Britain possible, sources say

Published

on

By

The European Union’s Brexit negotiator told the bloc’s 27 national envoys to Brussels that he still hoped a trade deal with Britain was possible, stressing that the coming days would be decisive, diplomatic sources with the bloc told Reuters, write and

Michel Barnier addressed the gathering on Wednesday (16 September) and the three sources either participated in the discussion behind closed doors or were briefed on its content.

“Barnier still believes a deal is possible though the next days are key,” said one of the EU diplomatic sources.

A second diplomat, asked what Barnier said on Wednesday and whether there was still a chance for a new agreement with the UK, said: “The hope is still there.”

The first source said tentative concessions offered by the UK on fisheries - a key point of discord that has so far prevented agreement on a new EU-UK trade deal to kick in from 2021 - were “a glimmer of hope”.

Reuters reported exclusively on Tuesday (15 September) that Britain has moved to break the deadlock despite that fact that publicly London has been threatening to breach the terms of its earlier divorce deal with the bloc.

A third source, a senior EU diplomat, confirmed the UK offer but stressed it was not going far enough for the bloc to accept.

Brexit talks descended into fresh turmoil this month over Prime Minister Boris Johnson’s plans to pass new domestic laws that would undercut London’s earlier EU divorce deal, which is also aimed at protecting peace on the island of Ireland.

US Democratic presidential candidate Joe Biden warned Britain that it must honour the Northern Irish peace deal as it extracts itself from the EU or there would be no US trade deal for the United Kingdom.

The third EU source, who spoke under condition of anonymity, said that the bloc would take a more rigid line in demanding a solid dispute settlement mechanism in any new UK trade deal should Johnson press ahead with the Internal Market Bill.

“There is unease about what Britain is doing but Barnier has stressed he will keep negotiating until his last breath,” said a fourth EU diplomat, highlighting the bloc’s wariness about being assigned blame should the troubled process eventually fail.

Asked about an estimate by Societe Generale bank, which put at 80% the probability of the most damaging economic split at the end of the year without a new deal to carry forward trade and business ties between the EU and the UK, the person said:

“I would put it around the same mark.”

Barnier is due to meet his UK counterpart, David Frost, around 1400 GMT in Brussels on Thursday.

Continue Reading

Brexit

Biden warns UK on #Brexit - No trade deal unless you respect Northern Irish peace deal

Published

on

By

US Democratic presidential candidate Joe Biden warned the United Kingdom that it must honour the Northern Irish peace deal as it extracts itself from the European Union or there would be no US trade deal, write and

“We can’t allow the Good Friday Agreement that brought peace to Northern Ireland to become a casualty of Brexit,” Biden said in a tweet.

“Any trade deal between the US and UK must be contingent upon respect for the Agreement and preventing the return of a hard border. Period.”

Johnson unveiled legislation that would break parts of the Brexit divorce treaty relating to Northern Ireland, blaming the EU for putting a revolver on the table in trade talks and trying to divide up the United Kingdom.

He says the United Kingdom has to have the ability to break parts of the 2020 Brexit treaty he signed to uphold London’s commitments under the 1998 peace deal which ended three decades of sectarian violence in Northern Ireland between pro-British Protestant unionists and Irish Catholic nationalists.

The EU says any breach of the Brexit treaty could sink trade talks, propel the United Kingdom towards a messy exit when it finally leaves informal membership at the end of the year and thus complicate the border between Northern Ireland and EU-member Ireland.

The EU’s Brexit negotiator told the bloc’s 27 national envoys that he still hoped a trade deal with Britain was possible, stressing that the coming days would be decisive, three diplomatic sources told Reuters.

Michel Barnier addressed the gathering on Wednesday and the three sources either participated in the discussion behind closed doors or were briefed on its content.

“Barnier still believes a deal is possible though the next days are key,” said one of the EU diplomatic sources.

Johnson told The Sun that the EU was being “abusive” to Britain and risking four decades of partnership.

He said the UK must “ring-fence” the Brexit deal “to put in watertight bulkheads that will stop friends and partners making abusive or extreme interpretations of the provisions.”

Societe Generale analysts said on Thursday they now see an 80% chance that Britain and the EU will fail to strike a trade deal before the end of the year.

Biden, who has talked about the importance of his Irish heritage, retweeted a letter from Eliot Engel, chair of the Foreign Affairs Committee of the US House of Representatives, to Johnson calling on the British leader to honour the 1998 Good Friday peace deal.

Engel urged Johnson to “abandon any and all legally questionable and unfair efforts to flout the Northern Ireland protocol of the Withdrawal Agreement.”

He called on Johnson to “ensure that Brexit negotiations do not undermine the decades of progress to bring peace to Northern Ireland and future options for the bilateral relationship between our two countries.”

Engel said Congress would not support a free trade agreement between the United States and the United Kingdom if Britain failed to uphold its commitments with Northern Ireland.

The letter was signed by Representatives Richard Neal, William Keating and Peter King.

Johnson is pushing ahead with his plan.

His government reached a deal on Wednesday (16 September) to avert a rebellion in his own party, giving parliament a say over the use of post-Brexit powers within its proposed Internal Market Bill that breaks international law.

Continue Reading
Advertisement

Facebook

Twitter

Trending